Calcitonin Gene-Related Peptide Receptor Antagonists
DBCAT005079Therapeutic category
Pharmacologic agents that block NOCICEPTIVE PAIN signaling from CALCITONIN GENE-RELATED PEPTIDE RECEPTORS. They may be useful for the treatment of pain associated with MIGRAINE DISORDERS and OSTEOARTHRITIS. A DrugBank category of 8 drugs. 7 of them are approved.
- Also known as
- Calcitonin Gene-Related Peptide (CGRP) Receptor Antagonists
What you can answer from here — as of September 21, 2021
Which targets do Calcitonin Gene-Related Peptide Receptor Antagonists share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account